NCD Policy Lab

21/10/2026

How can countries negotiate better prices for diabetes care when they don't know what others are paying?

Access to reliable procurement price data remains a challenge, yet greater transparency can help countries make more informed purchasing decisions and improve access to essential diabetes medicines and technologies.
📄 This new comparative study, in collaboration with , examines public procurement prices for diabetes-related products across participating countries, while exploring opportunities for more systematic price monitoring.

Beyond price differences, the findings raise important questions about procurement practices, data sharing and equitable access to care.
👉 Swipe through the highlights and explore the full report: https://ncdpolicylab.org/resources/reports/comparative-analysis-of-public-procurement-prices-for-diabetes-medicines-and-other-health-products

This report was co-funded by the Swiss Agency for Development and Cooperation and by Health Action International through the Study. The analysis and reflections presented in this report are those of the authors and do not necessarily reflect the views of the funders.

University of Geneva, Health Action International

13/10/2026

Better type 1 diabetes data. But for whom, and for what purpose?

People living with , healthcare professionals, researchers and policymakers all need reliable data. Yet, across the world, important gaps remain, and information is often fragmented. This new expert engagement report, “Designing the ideal data environment for type 1 diabetes”, from the Lancet Diabetes & Endocrinology Commission on type 1 diabetes , explores how data systems can be more connected, trustworthy and responsive to different needs and contexts.

One key message: collecting data is not the end goal. Using it to improve care is.

👉 Swipe through to discover some of the key takeaways.
Read the full report: https://ncdpolicylab.org/projects/the-lancet-diabetes-endocrinology-commission-on-type-1-diabetes



The Lancet Diabetes & Endocrinology Commission on Type 1 Diabetes receives funding from Breakthrough T1D and the World Diabetes Foundation as well as overall coordination support from the Swiss Development & Cooperation.

02/10/2026

Last week marked the official launch of the DIAMOND 2A Epidemiology Platform for Type 1 Diabetes, now live and accessible online! 🚀

This new interactive tool to explore, compare and use type 1 diabetes epidemiological data worldwide. As users, you can:

• Explore data by country or territory
• Test alternative epidemiological scenarios
• Download key country and regional data

A warm thank you to everyone who joined the webinar, and especially to the speakers and panelists David Beran, Anders Green, Sarah Wild, Janeth Tenorio Mucha and kaushik Ramaiya for sharing their expertise and contributing to the discussion.

🔗 Explore the platform: https://ncdpolicylab.org/projects/diamond-2a-epidemiology-platform-for-t1-diabetes
🎥 Watch the launch webinar recording: https://youtu.be/Q5ylXkldk7k?si=BThyOaio1lKOvXXO

Watch the recording of the official launch webinar of the DIAMOND 2...

30/09/2026

Do you remember ?

One year ago this month, LIVING WITH was unveiled on Geneva’s Quai Wilson, bringing together 56 portraits documenting the realities and challenges of living with type 1 diabetes, from Geneva to Bamako, through the lenses of photographers Antoine Martin and kalapo john.

One year later, the stories, faces and conversations behind these images continue to resonate.

If you missed the exhibition, or simply want to revisit it, LIVING WITH is still available online 👉 https://ncdpolicylab.org/activities/exhibition/living-with

But the story doesn’t end there.

We’ve been working on something special behind the scenes. More to come in the coming weeks!


Université de Genève, Hôpitaux Universitaires de Genève, ONG Santé Diabète, Fondation vivre avec le diabète de type 1
Swiss Development & Cooperation, Ville de Genève

21/09/2026

Only a few days left to register ⏳

On 24 September, join us online for the official launch of the DIAMOND 2A Epidemiology Platform for Type 1 Diabetes.

The platform offers a new way to explore epidemiological data and develop alternative epidemiological scenarios for any country or territory worldwide.

During the 60-minute session, Anders Green and David Beran will introduce the platform, discuss the data gaps it aims to address, and take participants through a practical demonstration of the tool.
The session will wrap up with a panel discussion and live Q&A featuring Sarah Wild, Janeth Tenorio Mucha, and Kaushik Ramaiya bringing different perspectives on how the platform could be used across research, policy, planning and advocacy.

🗓️ 24 September 2026 - 16:00 CEST | 14:00 UTC | 10:00 EDT | 19:30 IST
If you have not registered yet, there is still time to join us.

🔗 Register here: https://unige.zoom.us/webinar/register/WN_gFdHnggpTZeaFK2c7HvSNg

17/09/2026

🎙️ Meet the speakers for the DIAMOND 2A tool virtual launch

From the global data challenge to a guided introduction to the tool and a live discussion, this session will bring together experts helping shape the conversation around type 1 diabetes epidemiology.

Speakers and panelists: David Beran, Anders Green, Sarah Wild, Janeth Tenorio Mucha, kaushik Ramaiya

📅 24 September 2026
16:00 (CEST) | 14:00 (UTC) | 10:00 (EDT) | 19:30 (IST)

If you haven’t registered yet, there is still time!
🔗 https://unige.zoom.us/webinar/register/WN_gFdHnggpTZeaFK2c7HvSNg

Université de Genève, Steno Diabetes Center Odense, Haute Ecole du Paysage, Ingénierie et Architecture (HEPIA), Swiss Development & Cooperation

14/09/2026

What if exploring type 1 diabetes in your country were simple, intuitive and just a few clicks away?

📢 Registration is now open for the virtual launch of the DIAMOND 2A Epidemiology Platform for Type 1 Diabetes , a new tool providing access to Type 1 Diabetes epidemiological data and allowing users to explore the data and test different modelling scenarios for any country or territory.

The tool offers an interactive way to work with epidemiological estimates and explore how different assumptions can shape the picture of .

Developed by Anders Green (Steno Diabetes Center Odense) and David Beran (Université de Genève), and built by our partner Haute école du paysage, d'ingénierie et d'architecture de Genève - HEPIA as part of the NCD Policy Lab, supported by the Swiss Development & Cooperation.

📅 Virtual launch: 24 September 2026

🔗 Register here: https://unige.zoom.us/webinar/register/WN_gFdHnggpTZeaFK2c7HvSNg

We hope to see many of you there, join us for the launch! 🚀

08/09/2026

Where does access to an essential NCD medicine actually break down? Is it selection, regulation, forecasting, procurement or pricing?

📘Advancing Access is a new practical toolkit developed by the NCD Policy Lab (Université de Genève) and NCD Alliance to help advocates answer exactly that question, and turn the findings into action.
With practical checklists, advocacy strategies and a Follow-the-Product approach, the toolkit helps identify barriers, gather evidence and develop advocacy actions adapted to national contexts.

Explore the toolkit 👇:
https://ncdpolicylab.org/resources/toolkits/advancing-access-a-practical-advocacy-toolkit-for-improving-access-to-ncd-medicines-diagnostics-and-medical-devices

The toolkit journey builds on ideas first explored during the in Geneva in June 2025!💡



Université de Genève, NCD Alliance

02/09/2026

📢 Big news! DIAMOND 2A ( ) is launching a new online tool that puts type 1 diabetes epidemiological data at your fingertips.
With this epidemiology platform for type 1 diabetes, you can explore key data on for countries around the world, build alternative epidemiological scenarios, and download the data you need, all in one place.

This platform was developed by Anders Green (Steno Diabetes Center Odense SDCO) in collaboration with David Beran (Université de Genève), as part of a Visiting Professorship to SDCO funded by the Danish Diabetes and Endocrine Academy. The web-based platform itself was built by our partner as part of the NCD Policy Lab, supported by Swiss Development & Cooperation.

Save the date and join us for the official virtual launch on 24 September 2026 to learn more and see the tool in action!
Details and registration link to follow👀

13/07/2026

À Djibouti, Santé Diabète et l’Université de Genève, avec le soutien du Ministère de la Santé, ont conduit une évaluation de l’accès à l’insuline, en utilisant ce médicament essentiel comme traceur de la prise en charge du diabète.

Cette analyse a permis d’examiner l’ensemble de la chaîne de soins : approvisionnement, organisation du système de santé, disponibilité des traitements, accès aux soins et accessibilité financière.

Des visites de terrain ont été réalisées à tous les niveaux de la pyramide sanitaire, à Djibouti-Ville comme dans les régions, avant une restitution des résultats au Secrétaire Général du Ministère de la Santé.

Université de Genève, ONG Santé Diabète